Pathways associated with the risk of AD and other dementia, such as lipid metabolism, cardiovascular and cerebrovascular diseases, altered efferocytosis, inflammation, trafficking, and integrated stress response, are also associated with APOE.13, 14, 15, 16, 17, 18. This evidence concerns the gene APOE and dementia.